Back to top
more

West Pharmaceutical Services (WST)

(Delayed Data from NYSE)

$314.77 USD

314.77
496,482

-1.73 (-0.55%)

Updated Nov 4, 2024 04:00 PM ET

After-Market: $315.11 +0.34 (0.11%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth B Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (101 out of 250)

Industry: Medical - Dental Supplies

Zacks News

Zacks Industry Outlook Highlights: McKesson Corp, West Pharmaceutical Services, Cardinal Health, Align Technology and Dentsply Sirona

Zacks Industry Outlook Highlights: McKesson Corp, West Pharmaceutical Services, Cardinal Health, Align Technology and Dentsply Sirona

Trina Mukherjee headshot

3 Stocks to Capitalize on Promising Dental Supplies Industry

Despite the challenges thrown by the COVID-19 pandemic, teledentistry coupled with AI & Robotics should lend support to the Zacks Medical - Dental Supplies industry. MCK, WST and CAH are well-poised to gain from the prospects.

Sreoshi Bera headshot

Steady Rise in ESG Investing to Boost These 5 Stocks

ESG investing will continue its northward momentum and this calls for investing in NVIDIA (NVDA), Microsoft (MSFT), EMCOR (EME), West Pharma (WST) and Texas Instruments (TXN)

West Pharmaceutical Services (WST) Q4 Earnings and Revenues Beat Estimates

West Pharmaceutical (WST) delivered earnings and revenue surprises of 18.58% and 7.04%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Debanjana Dey headshot

5 MedTech Stocks That Have Outperformed the Industry in 2020

Here are a few MedTech stocks which continued to outperform their respective industries amid the pandemic and can turn out to be wise investment choices.

Trina Mukherjee headshot

Grab 3 Dental Stocks More Than Doubling Industry Gains for 2021

Buy these three top dental stocks that have shown sharp recovery despite market volatility due to the pandemic, and have the potential to continue their bull run in 2021.

MCK vs. WST: Which Stock Is the Better Value Option?

MCK vs. WST: Which Stock Is the Better Value Option?

Has West Pharmaceutical Services (WST) Outpaced Other Medical Stocks This Year?

Is (WST) Outperforming Other Medical Stocks This Year?

Is West Pharmaceutical Services (WST) Outperforming Other Medical Stocks This Year?

Is (WST) Outperforming Other Medical Stocks This Year?

Rimmi Singhi headshot

COVID-19 Vaccine Rollout Challenges Put These Stocks in Focus

With COVID-19 vaccine on the horizon, cold-chain storage stocks including TT, CARR and TMO; vial makers like GLW and WST; and logistic operators including UPS and FDX are set to hog the limelight.

Tivity Health's (TVTY) Shares Fall Despite Q3 Earnings Beat

Tivity Health (TVTY) reports solid revenue growth in its Nutrition arm in the third quarter due to strength in Nutrisystem brand DTC.

Has West Pharmaceutical Services (WST) Outpaced Other Medical Stocks This Year?

Is (WST) Outperforming Other Medical Stocks This Year?

Owens & Minor's (OMI) Shares Fall Despite Q3 Earnings Beat

Owens & Minor (OMI) reports solid revenue growth in its Global Products arm in the third quarter due to strength in PPE sales.

Hill-Rom (HRC) Q4 Earnings, Revenues Top Estimates, Fall Y/Y

In Q3, Hill-Rom's (HRC) bed orders and backlog in the United States accelerates with sequential recovery in Patient Support Systems arm.

Myriad Genetics' (MYGN) Q1 Earnings & Revenues Top Estimates

Myriad Genetics' (MYGN) sales in majority of the operating segments plummeted in the quarter owing to the pandemic-led business challenges.

National Vision (EYE) Q3 Earnings Top Estimates, Margins Up

National Vision (EYE) witnesses comparable growth on increased customer transaction in Q3.

Tandem Diabetes (TNDM) Q3 Earnings Miss, '20 Sales View Up

Tandem Diabetes' (TNDM) strong domestic pump sales and pump shipments boosted the top line.

CVS Health (CVS) Q3 Earnings Top Estimates, 2020 View Up

CVS Health's (CVS) Q3 pharmacy claims processed rise attributable to strong net new business, partially offset by reduced new therapy prescriptions.

Zimmer Biomet (ZBH) Q3 Earnings Beat, Gross Margin Contracts

Zimmer Biomet (ZBH) registers stronger-than-expected recovery of elective procedures in the third quarter.

Phibro (PAHC) Q1 Earnings Surpass Estimates, Margins Up

Phibro's (PAHC) core Animal Health segment, along with strength in Nutritional Specialties and Vaccines, boosted Q1 performance despite pandemic-led business disruptions.

Cardiovascular Systems' (CSII) Q1 Earnings Top Estimates

Cardiovascular Systems (CSII) registers dismal segmental revenues despite gradual recovery in business amid the pandemic.

Haemonetics (HAE) Q2 Earnings Beat Estimates, Margins Down

Haemonetics' (HAE) second-quarter fiscal 2021 results reflect impressive performance by Hospital segment despite dismal overall performance during the coronavirus-led crisis.

Novo Nordisk (NVO) Catches Eye: Stock Jumps 7.2%

Novo Nordisk (NVO) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.

Hologic (HOLX) Q4 Earnings Surpass Estimates, Margins Rise

Hologic (HOLX) exhibited robust segmental growth in fourth-quarter fiscal 2020 driven by strong performance by the Diagnostics segment amid the coronavirus pandemic.

Intersect ENT (XENT) Q3 Earnings and Revenues Beat Estimates

Intersect ENT's (XENT) PROPEL implants gain momentum and recapture procedure volume in Q3 following the drop in elective sinus procedures.